source
- Trump threatens up to 200% tariffs on generic drugs not manufactured in the United StatesPresident Donald Trump announced that his administration will consider imposing steep tariffs on generic medicines that are imported rather than produced in the United States. The proposed tariffs…
- Repligen to acquire BioLife Solutions for $1.5 billion, boosting its role in cell therapy preservationRepligen announced a $1.5 billion acquisition of BioLife Solutions, a company whose CryoStor media is used to preserve cell therapies during storage and transport. BioLife’s products are employed…